McCallum Stewart 4
4 · Recro Pharma, Inc. · Filed Jan 22, 2018
Insider Transaction Report
Form 4
McCallum Stewart
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-01-18+6,000→ 33,701 total - Tax Payment
Common Stock
2018-01-18$8.89/sh−1,860$16,535→ 31,841 total - Exercise/Conversion
Restricted Stock Units
2018-01-18−6,000→ 18,000 total→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On January 18, 2017, the reporting person was granted 24,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.